The Science Behind Immunotherapy for ALL

“It’s harnessing the power of our own immune systems to fight cancer,” says Dr. Patrick Brown, speaking about the use of immunotherapy in treating acute lymphoblastic leukemia (ALL). Dr. Brown, an ALL expert from the Kimmel Cancer Center at Johns Hopkins, joined Patient Power Co-Founder Esther Schorr at the 2019 American Society of Hematology (ASH) Annual Meeting & Exposition.

In this video, Dr. Brown explains the science behind immunotherapy, and provides examples of how different types of immunotherapy work. Watch now to learn from an ALL expert.

Key Takeaways

  • The advent of immunotherapy for treating several types of cancer, including ALL, is one of the more significant medical advances from the past five years.
  • Immunotherapy is not a single technology—BiTEs, CARs and ADCs, for example, are three different types of immunotherapy.
  • In ALL, the immunotherapy that has proven to be most successful so far uses antibodies to target specific proteins on the surface of cells.
© 2024 HealthCentral LLC. All rights reserved.

More on Acute Lymphoblastic Leukemia